Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 27;5(1):e8884.
doi: 10.1371/journal.pone.0008884.

Risk of ovarian cancer and inherited variants in relapse-associated genes

Abraham Peedicayil  1 , Robert A Vierkant, Lynn C Hartmann, Brooke L Fridley, Zachary S Fredericksen, Kristin L White, Elaine A Elliott, Catherine M Phelan, Ya-Yu Tsai, Andrew Berchuck, Edwin S Iversen Jr, Fergus J Couch, Prema Peethamabaran, Melissa C Larson, Kimberly R Kalli, Matthew L Kosel, Vijayalakshmi Shridhar, David N Rider, Mark Liebow, Julie M Cunningham, Joellen M Schildkraut, Thomas A Sellers, Ellen L Goode
Affiliations

Risk of ovarian cancer and inherited variants in relapse-associated genes

Abraham Peedicayil et al. PLoS One. .

Abstract

Background: We previously identified a panel of genes associated with outcome of ovarian cancer. The purpose of the current study was to assess whether variants in these genes correlated with ovarian cancer risk.

Methods and findings: Women with and without invasive ovarian cancer (749 cases, 1,041 controls) were genotyped at 136 single nucleotide polymorphisms (SNPs) within 13 candidate genes. Risk was estimated for each SNP and for overall variation within each gene. At the gene-level, variation within MSL1 (male-specific lethal-1 homolog) was associated with risk of serous cancer (p = 0.03); haplotypes within PRPF31 (PRP31 pre-mRNA processing factor 31 homolog) were associated with risk of invasive disease (p = 0.03). MSL1 rs7211770 was associated with decreased risk of serous disease (OR 0.81, 95% CI 0.66-0.98; p = 0.03). SNPs in MFSD7, BTN3A3, ZNF200, PTPRS, and CCND1A were inversely associated with risk (p<0.05), and there was increased risk at HEXIM1 rs1053578 (p = 0.04, OR 1.40, 95% CI 1.02-1.91).

Conclusions: Tumor studies can reveal novel genes worthy of follow-up for cancer susceptibility. Here, we found that inherited markers in the gene encoding MSL1, part of a complex that modifies the histone H4, may decrease risk of invasive serous ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108. - PubMed
    1. Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, et al. Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res. 2005;11(6):2149–2155. - PubMed
    1. De Smet F, Pochet NL, De Moor BL, Van Gorp T, Timmerman D, et al. Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles. Clin Cancer Res. 2005;11(21):7958–7959; author reply 7959. - PubMed
    1. Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, et al. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Hum Mutat. 2007;28(12):1207–1215. - PubMed
    1. Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, et al. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Molecular oncology. 2009;3(2):97–137. - PMC - PubMed

Publication types